Impact of HPV infection on the development of head and neck cancer

Imagem de Miniatura
Arquivos
art_BETIOL_Impact_of_HPV_infection_on_the_development_of_2013.PDF (191.77 KB)
Citações na Scopus
34
Tipo de produção
article
Data de publicação
2013
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC BRAS DIVULG CIENTIFICA
Autores
Citação
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, v.46, n.3, p.217-226, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Human papillomavirus (HPV)-related head and neck squamous cell carcinoma (HNSCC) is considered to be a distinct clinical entity with better prognosis than the classical tobacco-and alcohol-associated tumors. The increasing incidence of this neoplasia during the last decades highlights the need to better understand the role of HPV in the development of these cancers. Although the proportion of HNSCC attributed to HPV varies considerably according to anatomical site, overall approximately 25% of all HNSCC are HPV-DNA positive, and HPV-16 is by far the most prevalent type. In this review we discuss the existing evidence for a causal association between HPV infection and HNSCC at diverse anatomical head and neck subsites.
Palavras-chave
Human papillomavirus, Oncogenic potential, Head and neck cancer, Viral prevalence
URI
https://observatorio.fm.usp.br/handle/OPI/2237
Referências
  1. American Cancer Society, 2012, CANC FACTS FIG 2012
  2. Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217
  3. Auluck A, 2010, CANCER-AM CANCER SOC, V116, P2635, DOI 10.1002/cncr.25087
  4. Baumann JL, 2009, LARYNGOSCOPE, V119, P1531, DOI 10.1002/lary.20509
  5. Bertolus Chloé, 2012, Infect Agent Cancer, V7, P13, DOI 10.1186/1750-9378-7-13
  6. BLOT WJ, 1988, CANCER RES, V48, P3282
  7. Bonagura VR, 2010, APMIS, V118, P455, DOI 10.1111/j.1600-0463.2010.02617.x
  8. BONNEZ W, 1992, VIROLOGY, V188, P384, DOI 10.1016/0042-6822(92)90770-P
  9. Boscolo-Rizzo P, 2009, J CANCER RES CLIN, V135, P559, DOI 10.1007/s00432-008-0490-3
  10. Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383
  11. Bouvard V, 2009, LANCET ONCOL, V10, P321
  12. Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321
  13. Burk Robert D, 2011, Acta Dermatovenerol Alp Panonica Adriat, V20, P113
  14. Castellsague X, 2004, INT J CANCER, V108, P741, DOI 10.1002/ijc.11627
  15. Castillo A, 2011, WORLD J GASTROENTERO, V17, P5295, DOI 10.3748/wjg.v17.i48.5295
  16. Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183
  17. Chernock Rebecca D, 2009, Head Neck Pathol, V3, P186, DOI 10.1007/s12105-009-0126-1
  18. Chu EA, 2008, OTOLARYNG CLIN N AM, V41, P673, DOI 10.1016/j.otc.2008.01.016
  19. Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024
  20. Cole L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032657
  21. Dahlstrom KR, 2008, HEAD NECK-J SCI SPEC, V30, P75, DOI 10.1002/hed.20664
  22. Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15
  23. de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033
  24. D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497
  25. Du J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036239
  26. Duray A, 2011, INT J ONCOL, V39, P51, DOI 10.3892/ijo.2011.1031
  27. El-Mofty SK, 2006, ORAL SURG ORAL MED O, V101, P339, DOI 10.1016/j.tripleo.2005.08.001
  28. Feller L, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-15
  29. Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
  30. Gelinas JF, 2008, INT J PEDIATR OTORHI, V72, P433, DOI 10.1016/j.ijporl.2007.12.003
  31. Gillison ML, 2000, J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709
  32. Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101
  33. Gillison ML, 2012, VACCINE, V30, pF34, DOI 10.1016/j.vaccine.2012.05.070
  34. Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1
  35. Gillison ML, 2001, CURR OPIN ONCOL, V13, P183, DOI 10.1097/00001622-200105000-00009
  36. Gillison ML, 2008, J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025
  37. Hannisdal K, 2010, ACTA OTO-LARYNGOL, V130, P293, DOI 10.3109/00016480903071377
  38. Hartwig S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-30
  39. HAWLEYNELSON P, 1989, EMBO J, V8, P3905
  40. Hemminki K, 2000, EUR J CANCER PREV, V9, P433, DOI 10.1097/00008469-200012000-00010
  41. Herrero R, 2003, J NATL CANCER I, V95, P1772, DOI 10.1093/jnci/djg/107
  42. Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x
  43. Hong A, 2012, ANN SURG ONCOL
  44. Hong AM, 2013, ANN ONCOL, V24, P215, DOI 10.1093/annonc/mds205
  45. Howlader N., 2009, SEER CANC STAT REV 1
  46. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC MONOGR EVAL CAR, V90, P1
  47. Jemal Ahmedin, 2011, CA Cancer J Clin, V61, P69, DOI 10.3322/caac.20107
  48. Jiang R, 2012, ORAL ONCOL, V48, P836, DOI 10.1016/j.oraloncology.2012.03.017
  49. Kaminagakura E, 2012, INT J CANCER, V130, P1726, DOI 10.1002/ijc.26185
  50. Katsenos Stamatis, 2011, Case Rep Oncol, V4, P162, DOI 10.1159/000327094
  51. Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0
  52. Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551
  53. Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b
  54. Kreimer AR, 2011, CANCER EPIDEM BIOMAR, V20, P172, DOI 10.1158/1055-9965.EPI-10-0682
  55. Kruse AL, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-24
  56. Lassen P, 2009, J CLIN ONCOL, V27, P1992, DOI 10.1200/JCO.2008.20.2853
  57. Lee LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040767
  58. Lingen MW, 2013, ORAL ONCOL, V49, P1, DOI 10.1016/j.oraloncology.2012.07.002
  59. Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004
  60. Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6
  61. Miguel REV, 1998, AM J SURG, V176, P428, DOI 10.1016/S0002-9610(98)00246-3
  62. MUNGER K, 1989, EMBO J, V8, P4099
  63. National Cancer Institute, 2000, SEER STAT DAT INC SE
  64. O'Connor MJ, 2000, J VIROL, V74, P401
  65. Pim D, 2010, APMIS, V118, P471, DOI 10.1111/j.1600-0463.2010.02618.x
  66. Ragin CCR, 2007, INT J CANCER, V121, P1813, DOI 10.1002/ijc.22851
  67. Ram Hari, 2011, J Maxillofac Oral Surg, V10, P132, DOI 10.1007/s12663-011-0195-z
  68. Rampias T, 2010, MOL CANCER RES, V8, P433, DOI 10.1158/1541-7786.MCR-09-0345
  69. Remmerbach TW, 2004, J CLIN VIROL, V30, P302, DOI 10.1016/j.jcv.2003.12.011
  70. Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249
  71. Rodriguez T, 2004, ORAL ONCOL, V40, P207, DOI 10.1016/S1368-8375(03)00168-4
  72. ROMANCZUK H, 1992, P NATL ACAD SCI USA, V89, P3159, DOI 10.1073/pnas.89.7.3159
  73. SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3
  74. Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8
  75. Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179
  76. Shi W, 2009, J CLIN ONCOL, V27, P6213, DOI 10.1200/JCO.2009.23.1670
  77. Shykhon M, 2002, CLIN OTOLARYNGOL, V27, P237, DOI 10.1046/j.1365-2273.2002.00555.x
  78. Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481
  79. Sichero L, 2006, BRAZ J MED BIOL RES, V39, P707, DOI 10.1590/S0100-879X2006000600002
  80. Silver RD, 2003, OTOLARYNG HEAD NECK, V129, P622, DOI 10.1016/j.otohns.2003.08.018
  81. Sinha P, 2012, AM J OTOLARYNG, V33, P130, DOI 10.1016/j.amjoto.2011.02.001
  82. Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257
  83. St Guily JL, 2011, J CLIN VIROL, V51, P100, DOI 10.1016/j.jcv.2011.03.003
  84. St Guily JL, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-22
  85. Sudhoff HH, 2011, EUR ARCH OTO-RHINO-L, V268, P1541, DOI 10.1007/s00405-011-1714-8
  86. SYRJANEN K, 1983, INT J ORAL MAXILLOF, V12, P418, DOI 10.1016/S0300-9785(83)80033-7
  87. Syrjanen S, 2007, NEW ENGL J MED, V356, P1993, DOI 10.1056/NEJMe078004
  88. Syrjanen S, 2010, ANN ONCOL, V21, P243, DOI 10.1093/annonc/mdq454
  89. Termine N, 2008, ANN ONCOL, V19, P1681, DOI 10.1093/annonc/mdn372
  90. Van Doorslaer K, 2011, TRENDS MICROBIOL, V19, P49, DOI 10.1016/j.tim.2010.11.004
  91. VILLA LL, 1991, VIROLOGY, V181, P374
  92. Villa LL, 2011, CANCER LETT, V305, P106, DOI 10.1016/j.canlet.2010.12.002
  93. Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002
  94. Weinberger PM, 2010, LARYNGOSCOPE, V120, P1531, DOI 10.1002/lary.20984
  95. *INCA, 2011, EST 2012 INC CANC BR

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - ODS/03